131 related articles for article (PubMed ID: 28663037)
1. Freeze dried solid dispersion of exemestane: A way to negate an aqueous solubility and oral bioavailability problems.
Kaur S; Jena SK; Samal SK; Saini V; Sangamwar AT
Eur J Pharm Sci; 2017 Sep; 107():54-61. PubMed ID: 28663037
[TBL] [Abstract][Full Text] [Related]
2. Alternative oral exemestane formulation: improved dissolution and permeation.
Yavuz B; Bilensoy E; Vural I; Sumnu M
Int J Pharm; 2010 Oct; 398(1-2):137-45. PubMed ID: 20678561
[TBL] [Abstract][Full Text] [Related]
3. Proliposomes of exemestane for improved oral delivery: formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine.
Hiremath PS; Soppimath KS; Betageri GV
Int J Pharm; 2009 Oct; 380(1-2):96-104. PubMed ID: 19616608
[TBL] [Abstract][Full Text] [Related]
4. Nanostructured Lipid Carriers for Oral Bioavailability Enhancement of Exemestane: Formulation Design, In Vitro, Ex Vivo, and In Vivo Studies.
Singh A; Neupane YR; Mangla B; Kohli K
J Pharm Sci; 2019 Oct; 108(10):3382-3395. PubMed ID: 31201904
[TBL] [Abstract][Full Text] [Related]
5. Lyophilized mixed micelles of exemestane: A novel paradigm to improve its absorption and anticancer activity.
Singh G; Kaur P; Singh D; Tiwary AK; Arora S; Bedi N
Arch Pharm (Weinheim); 2023 Aug; 356(8):e2200579. PubMed ID: 37276367
[TBL] [Abstract][Full Text] [Related]
6. Solubility enhancement of BCS Class II drug by solid phospholipid dispersions: Spray drying versus freeze-drying.
Fong SY; Ibisogly A; Bauer-Brandl A
Int J Pharm; 2015 Dec; 496(2):382-91. PubMed ID: 26468038
[TBL] [Abstract][Full Text] [Related]
7. Improvement of oral bioavailability of glycyrrhizin by sodium deoxycholate/phospholipid-mixed nanomicelles.
Jin S; Fu S; Han J; Jin S; Lv Q; Lu Y; Qi J; Wu W; Yuan H
J Drug Target; 2012 Aug; 20(7):615-22. PubMed ID: 22726209
[TBL] [Abstract][Full Text] [Related]
8. Solid Phospholipid Dispersions for Oral Delivery of Poorly Soluble Drugs: Investigation Into Celecoxib Incorporation and Solubility-In Vitro Permeability Enhancement.
Fong SY; Martins SM; Brandl M; Bauer-Brandl A
J Pharm Sci; 2016 Mar; 105(3):1113-23. PubMed ID: 26886329
[TBL] [Abstract][Full Text] [Related]
9. Enhancing biopharmaceutical attributes of phospholipid complex-loaded nanostructured lipidic carriers of mangiferin: Systematic development, characterization and evaluation.
Khurana RK; Bansal AK; Beg S; Burrow AJ; Katare OP; Singh KK; Singh B
Int J Pharm; 2017 Feb; 518(1-2):289-306. PubMed ID: 28025072
[TBL] [Abstract][Full Text] [Related]
10. Enhanced bioavailability of exemestane via proliposomes based transdermal delivery.
Jukanti R; Sheela S; Bandari S; Veerareddy PR
J Pharm Sci; 2011 Aug; 100(8):3208-3222. PubMed ID: 21404279
[TBL] [Abstract][Full Text] [Related]
11. Development of omega-3 phospholipid-based solid dispersion of fenofibrate for the enhancement of oral bioavailability.
Yang L; Shao Y; Han HK
Eur J Pharm Sci; 2015 Oct; 78():103-10. PubMed ID: 26165620
[TBL] [Abstract][Full Text] [Related]
12. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
Jain S; Reddy VA; Arora S; Patel K
Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
[TBL] [Abstract][Full Text] [Related]
13. Enhanced dissolution and oral bioavailability of valsartan solid dispersions prepared by a freeze-drying technique using hydrophilic polymers.
Xu WJ; Xie HJ; Cao QR; Shi LL; Cao Y; Zhu XY; Cui JH
Drug Deliv; 2016; 23(1):41-8. PubMed ID: 24735247
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of the aqueous solubility and permeability of a poorly water soluble drug ritonavir via lyophilized milk-based solid dispersions.
Dhore PW; Dave VS; Saoji SD; Bobde YS; Mack C; Raut NA
Pharm Dev Technol; 2017 Feb; 22(1):90-102. PubMed ID: 27291246
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of dissolution and oral bioavailability by adjusting microenvironment pH in crocetin ternary solid dispersions: Optimization, characterization, in vitro evaluation, and pharmacokinetics.
Tong Z; Liu X; Tao Y; Feng P; Luan F; Jie X; Xie Z; Pu F; Xu Z; Wang P
Drug Deliv Transl Res; 2024 Jul; 14(7):1923-1939. PubMed ID: 38117406
[TBL] [Abstract][Full Text] [Related]
16. Phospholipid-based solid drug formulations for oral bioavailability enhancement: A meta-analysis.
Fong SY; Brandl M; Bauer-Brandl A
Eur J Pharm Sci; 2015 Dec; 80():89-110. PubMed ID: 26296863
[TBL] [Abstract][Full Text] [Related]
17. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies.
Zhang Z; Chen Y; Deng J; Jia X; Zhou J; Lv H
Int J Pharm; 2014 Apr; 465(1-2):306-16. PubMed ID: 24456672
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
Liu J; Qiu L; Gao J; Jin Y
Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
[TBL] [Abstract][Full Text] [Related]
19. Formulation of Dronedarone Hydrochloride-Loaded Proliposomes: In Vitro and In Vivo Evaluation Using Caco-2 and Rat Model.
Kovvasu SP; Kunamaneni P; Yeung S; Rueda J; Betageri GV
AAPS PharmSciTech; 2019 Jun; 20(6):226. PubMed ID: 31214813
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]